Our platform, termed epigenetic restoration, has been shown to rejuvenate cells in preclinical models with profound therapeutic effect. It has the potential to rejuvenate cells and restore function in many age-related diseases.

We are the sole company with intellectual property covering the therapeutic use of our epigenetic restoration technology. We are also the only company to have received FDA approval to advance this technology into human clinical studies. While our initial clinical trial is for optic neuropathies, our science has the potential to bring tremendous benefit to patients suffering from multiple age-related diseases.

Life Biosciences is headquartered in Boston, MA.

The Opportunity

• 80% of those over 60 years of age have at least one age-related illness; 50% have two or more
• 30% of people ages 65 or older in OECD (Organization for Economic Cooperation and Development) countries need assistance with activities of daily living
• The proportion of the world’s population over 60 years of age will nearly double from 12% in 2015 to 22% in 2050